95 results
Page 2 of 5
144
upei5
26 Mar 24
Notice of proposed sale of securities
5:37pm
424B3
s0eca
12 Mar 24
Prospectus supplement
4:18pm
POS AM
nzdk rk478cl30aipsgw
28 Feb 24
Prospectus update (post-effective amendment)
5:01pm
POS AM
EX-5.1
gz9woql
28 Feb 24
Prospectus update (post-effective amendment)
5:01pm
8-K
EX-99.1
vn5heunqtqwleh99
28 Feb 24
NewAmsterdam Pharma Reports Full Year 2023 Financial Results and Provides Corporate Update
8:11am
10-K
EX-10.8
hjn78h3 v23fw
28 Feb 24
Annual report
8:00am
10-K
EX-97.1
2l6giv2ne4u1znyf
28 Feb 24
Annual report
8:00am
10-K
EX-10.9
e26u20nws n2829c8k
28 Feb 24
Annual report
8:00am
10-K
EX-10.4
jz5f5a zt88qhnt5e
28 Feb 24
Annual report
8:00am
10-K
d91 74usmee
28 Feb 24
Annual report
8:00am
10-K
EX-10.7
zmunfexp8d0ci1a
28 Feb 24
Annual report
8:00am
8-K
EX-1.1
i7z4e0cwh 53bj
15 Feb 24
NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
4:18pm
8-K
EX-4.1
yowvj61lb86 nx5p
15 Feb 24
NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
4:18pm
8-K
EX-5.1
86osvu551k8qo3tmc2
15 Feb 24
NewAmsterdam Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
4:18pm
424B5
88s6d1
15 Feb 24
Prospectus supplement for primary offering
4:15pm
424B5
yw5pi
13 Feb 24
Prospectus supplement for primary offering
5:19pm
424B3
7z0j2vln84lfv3
19 Dec 23
Prospectus supplement
4:36pm
F-3
EX-4.1
cb5dvw70c55
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
EX-4.2
oyzpt4
7 Dec 23
Shelf registration (foreign)
4:16pm
F-3
EX-1.2
8ywa1yu34
7 Dec 23
Shelf registration (foreign)
4:16pm